Skip to main content
Top
Published in: Annals of Hematology 3/2010

01-03-2010 | Original Article

Sheehan’s syndrome with pancytopenia—complete recovery after hormone replacement (case series with review)

Authors: Bashir Ahmad Laway, Javid Rasool Bhat, Shahnaz Ahmad Mir, Raja Sultan Zaman Khan, Mohd Iqbal Lone, Abdul Hamid Zargar

Published in: Annals of Hematology | Issue 3/2010

Login to get access

Abstract

Reports of pancytopenia in patients with Sheehan’s syndrome are rare, because the disorder is not commonly seen in western countries. A case series of pancytopenia in three patients of Sheehan’s syndrome is presented. Three women aged 22, 30, and 34 years developed Sheehan’s syndrome preceded by post partum hemorrhage. During investigations, they were found to have pancytopenia with hypocellular marrow. Treatment with thyroxine and glucocorticoids resulted in complete recovery after attaining euthyroid and eucortisolemic state. Review of literature revealed the rarity of the disorder, with only four cases reported so far. Multiple anterior pituitary hormone deficiencies in Sheehan’s syndrome are responsible for pancytopenia; replacement of thyroid and cortisol hormones results in complete recovery.
Literature
1.
go back to reference Sheehan HL (1954) The incidence of postpartum hypopituitarism. Am J Obstet Gynecol 68:202–223PubMed Sheehan HL (1954) The incidence of postpartum hypopituitarism. Am J Obstet Gynecol 68:202–223PubMed
2.
go back to reference Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI, Bashir MI (2005) Epidemiological aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril 84:523–528CrossRefPubMed Zargar AH, Singh B, Laway BA, Masoodi SR, Wani AI, Bashir MI (2005) Epidemiological aspects of postpartum pituitary hypofunction (Sheehan’s syndrome). Fertil Steril 84:523–528CrossRefPubMed
4.
go back to reference Gokalp D, Tuzcu A, Bahceci M, Arikan S, Bahceci S, Pasa S (2009) Sheehan’s syndrome as a rare cause of anemia secondary to hypopituitarism. Ann Hematol 88:405–410CrossRefPubMed Gokalp D, Tuzcu A, Bahceci M, Arikan S, Bahceci S, Pasa S (2009) Sheehan’s syndrome as a rare cause of anemia secondary to hypopituitarism. Ann Hematol 88:405–410CrossRefPubMed
5.
go back to reference Ferrari E, Ascari E, Bossolo PA, Barosi G (1976) Sheehan’s syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol 33:575–582CrossRefPubMed Ferrari E, Ascari E, Bossolo PA, Barosi G (1976) Sheehan’s syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol 33:575–582CrossRefPubMed
6.
go back to reference Ozdogan M, Yazicioglu G, Karadogan I, Cevikol C, Karayalcin U, Undar L (2004) Sheehan’s syndrome associated with pancytopenia due to marrow aplasia: full recovery with hormone replacement therapy. Int J Clin Pract 58:533–535CrossRefPubMed Ozdogan M, Yazicioglu G, Karadogan I, Cevikol C, Karayalcin U, Undar L (2004) Sheehan’s syndrome associated with pancytopenia due to marrow aplasia: full recovery with hormone replacement therapy. Int J Clin Pract 58:533–535CrossRefPubMed
7.
go back to reference Kim DY, Kim JH, Park YJ, Jung KH, Chung HS, Shin S, Yun SS, Park S, Kim BK (2004) Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol 83:309–312CrossRefPubMed Kim DY, Kim JH, Park YJ, Jung KH, Chung HS, Shin S, Yun SS, Park S, Kim BK (2004) Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol 83:309–312CrossRefPubMed
8.
go back to reference Akoz AG, Atmaca H, Ustundag Y, Ozdamar SO (2007) An unusual case of pancytopenia associated with Sheehan’s syndrome. Ann Hematol 86:307–308CrossRef Akoz AG, Atmaca H, Ustundag Y, Ozdamar SO (2007) An unusual case of pancytopenia associated with Sheehan’s syndrome. Ann Hematol 86:307–308CrossRef
9.
go back to reference Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N (2002) Pituitary autoimmunity in patients with Sheehan’s syndrome. J Clin Endocrinol Metab 87:4137–4141CrossRefPubMed Goswami R, Kochupillai N, Crock PA, Jaleel A, Gupta N (2002) Pituitary autoimmunity in patients with Sheehan’s syndrome. J Clin Endocrinol Metab 87:4137–4141CrossRefPubMed
10.
go back to reference Zargar AH, Masoodi SR, Laway BA, Shah NA, Salahuddin M, Siddiqi MA (1996) Clinical spectrum of Sheehan’s syndrome. Ann Saudi Med 16:338–341PubMed Zargar AH, Masoodi SR, Laway BA, Shah NA, Salahuddin M, Siddiqi MA (1996) Clinical spectrum of Sheehan’s syndrome. Ann Saudi Med 16:338–341PubMed
11.
go back to reference Zargar AH, Masoodi SR, Laway BA, Sofi FA, Wani AI (1998) Pregnancy in Sheehan’s syndrome: a report of three cases. J Assoc Phys India 46:476–478 Zargar AH, Masoodi SR, Laway BA, Sofi FA, Wani AI (1998) Pregnancy in Sheehan’s syndrome: a report of three cases. J Assoc Phys India 46:476–478
Metadata
Title
Sheehan’s syndrome with pancytopenia—complete recovery after hormone replacement (case series with review)
Authors
Bashir Ahmad Laway
Javid Rasool Bhat
Shahnaz Ahmad Mir
Raja Sultan Zaman Khan
Mohd Iqbal Lone
Abdul Hamid Zargar
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 3/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0804-9

Other articles of this Issue 3/2010

Annals of Hematology 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine